Evaluation of effect of non-ablative non-thermal laser therapy on trigeminal neuralgia

Evaluation of effect of non-ablative non-thermal co2 laser therapy(NANTL) on trigeminal neuralgia(double blind randomized clinical trial)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013052113406N1

Enrollment

Registered

2013-12-25

Start date

2013-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia. Trigeminal neuralgia

Interventions

Intervention 1: treatment with laser in intervention group. Intervention 2: sham laser in control group.

Treatment - Other

sham laser in control group

treatment with laser in intervention group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criterion: trigeminal neuralgia that use carbamazepin for treatment. Exclusion criteria: MS and postherpetic neuralgia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Immediately after treatment, 2 weeks after and 1, 2, 6 months after. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Mosalanegad

Shiraz University of Medical Sciences

mosalanegadf@sums.ac.ir+98 71 1634 7648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026